THEMIS BIOSCIENCE
Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The companyโs development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases. We aim to exploit the increasing licensing and acquisition trend to generate value by developing and partnering our technology programs and vaccine candidates. It is our mission to establish Themis as a first class biotech development boutique and to become a preferred licensing partner for leading biotech and pharmaceutical companies.
THEMIS BIOSCIENCE
Social Links:
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2009-09-01
Address:
Vienna, Wien, Austria
Country:
Austria
Website Url:
http://www.themisbio.com
Total Employee:
11+
Status:
Active
Contact:
(431) 236-7151
Email Addresses:
[email protected]
Total Funding:
150.22 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Pound Sterling MailChimp SPF
Similar Organizations
10xBio
10xBio, LLC, a privately-held biotechnology company
ACS Biotech
ACS Biotech is an innovative start up in biotechnology
ADC Biotechnology
ADC BIO is an innovative biotechnology company. Specialising in Antibody Drug Conjugates.
Amwise Diagnostic
Amwise Diagnostic is a leader in precision medicine technology for cancer.
Atavistik Bio
Atavistik Bio is a biotechnology company that focuses on the discovery and development of novel therapies for metabolic diseases and cancer.
Biognosys
Biognosys provides the best possible solutions to support researchers in their protein analysis needs.
Cygnus Biosciences
Cygnus Biosciences is a Chinese gene sequencing company.
CytoNiche
CytoNiche is a 3D bionic cell technology company.
Engitix
Engitix is operates as a tissue engineering company.
Geneius
Geneius is a Biotechnology company.
Genia Technologies
Genia Technologies is a biotechnology company.
Idogen
Idogen is a biotechnology company.
Ingenza
Ingenza is an industrial biotechnology company.
Ionova Life Science
Ionova Life Science IS a biotech company.
Jiksak Bioengineering
Jiksak Bioengineering is a biotechnology company.
Kankyo Daizen
Kankyo Daizen is a biotechnology company.
Konfoong Biotech International
Konfoong Biotech International is a biotech company.
KOTAI Biotechnologies
KOTAI Biotechnologies is a biotechnology company.
Lion TCR
Lion TCR is a clinical-stage biotechnology company.
Mojia Bioscience
Mojia Bioscience is a biotechnology company.
Neuraly
Neuraly is a startup biotech company.
Abliva AB
Abliva develops medicines for the treatment of primary mitochondrial diseases.
Origin Agritech
Origin Agritech is a leading agricultural biotechnology company.
Ovagen
Ovagen is a biotechnology company.
PKVitality
PKVitality is a bio-wearable company that develops smartwatches to monitor glucose.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
TikoMed
TikoMed is a biotechnology company.
Virometix
Virometix is a privately held biotechnology company developing
Zhongyianke Biotech
Zhongyianke Biotech is a biotechnology firm.
Current Advisors List
Current Employees Featured
Founder
Investors List
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations investment in Grant - Themis Bioscience
Omnes Capital
Omnes Capital investment in Series D - Themis Bioscience
aws Grรผnderfonds (aws Founders Fund)
aws Grรผnderfonds (aws Founders Fund) investment in Series D - Themis Bioscience
Global Health Investment Fund (GHIF)
Global Health Investment Fund (GHIF) investment in Series D - Themis Bioscience
Adjuvant Capital
Adjuvant Capital investment in Series D - Themis Bioscience
Hadean Ventures
Hadean Ventures investment in Series D - Themis Bioscience
Ventech
Ventech investment in Series D - Themis Bioscience
Merck
Merck investment in Series D - Themis Bioscience
Wellington Partners
Wellington Partners investment in Series D - Themis Bioscience
Farallon Capital Management
Farallon Capital Management investment in Series D - Themis Bioscience
Official Site Inspections
http://www.themisbio.com
- Host name: xserv20503.internex.at
- IP address: 85.126.241.61
- Location: Austria
- Latitude: 48.2
- Longitude: 16.3667
- Timezone: Europe/Vienna
More informations about "Themis Bioscience"
Themis Bioscience - Crunchbase Company Profile & Funding
Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The companyโs development focus is primarily concentrated on emerging and โฆSee details»
Themis Bioscience - Ownership and Business Overview - Mergr
May 26, 2020 Themis Bioscience GmbH is a developer of immunomodulation therapies for infectious diseases and cancer. Through advanced understanding of immune system โฆSee details»
Themis Bioscience NV - Company Profile and News
Company profile page for Themis Bioscience NV including stock price, company news, executives, board members, and contact informationSee details»
ํ ํฐ์ค๋ฐ์ด์ค
Supio nm ๋ถ์ฐ ๋๊ตฌ ์ถฉ์ฅ๋๋ก160 ํ์ฑ๋ง๋ฆฌ๋ g7 supio thetis bio ์์ธ ์ฑ๋๊ตฌ ๊ณ ์ฐ์๋ก 202 ๋ฌดํ๋น๋ฉ 411 supio company ๋ถ์ฐ ์ฌ์๊ตฌ ์ฌ์๋ก ...See details»
Themis Bioscience - Products, Competitors, Financials, Employees ...
For instance, in September 2022, according to the World Health Organization, a Switzerland-based agency responsible for international public health, every year, 17 million people die from โฆSee details»
Merck Completes Acquisition of Themis - Merck.com
Jun 19, 2020 Milestone Reflects Merckโs Commitment to Accelerate SARS-CoV-2 Vaccine Program Merck (NYSE: MRK), known as MSD outside the United States and Canada, today โฆSee details»
Themis Bioscience GmbH - Life Sciences Directory
Organization type RDM biotech/pharma Region Vienna Cluster LISAvienna Focus human health Details. Lactosan GmbH. Organization type RDM biotech/pharma Region Styria Focus โฆSee details»
Themis Bioscience GmbH - BioCentury Company Profiles - BCIQ
Nov 15, 2021 Themis Bioscience GmbH - BioCentury Company Profiles for the biopharma industrySee details»
Themis Bioscience Announces Exclusive Licensing Agreement with โฆ
Nov 10, 2018 Themis announced today that it has entered into a license agreement with Max Planck Innovation GmbH, the technology transfer agency of the Max Planck Society in โฆSee details»
ํ ํฐ์ค๋ฐ์ด์ค - SUPPORT - THETIS BIO
Supio nm ๋ถ์ฐ ๋๊ตฌ ์ถฉ์ฅ๋๋ก160 ํ์ฑ๋ง๋ฆฌ๋ g7 supio thetis bio ์์ธ ์ฑ๋๊ตฌ ๊ณ ์ฐ์๋ก 202 ๋ฌดํ๋น๋ฉ 411 supio company ๋ถ์ฐ ์ฌ์๊ตฌ ์ฌ์๋ก ...See details»
ํ ํฐ์ค๋ฐ์ด์ค - thetisbio.com
Supio nm ๋ถ์ฐ ๋๊ตฌ ์ถฉ์ฅ๋๋ก160 ํ์ฑ๋ง๋ฆฌ๋ g7 supio thetis bio ์์ธ ์ฑ๋๊ตฌ ๊ณ ์ฐ์๋ก 202 ๋ฌดํ๋น๋ฉ 411 supio company ๋ถ์ฐ ์ฌ์๊ตฌ ์ฌ์๋ก ...See details»
Two Renowned Vaccine Experts Joining Themis Bioscience GmbH
Jan 21, 2016 Themis Bioscience GmbH has announced the appointment of two new leadership members, Dr. Philippe Dro and Dr. Christian Mandl. The appointment follows in the wake of โฆSee details»
Merck Will Buy Themis Bioscience, Enter Race for COVID-19 Vaccine
May 26, 2020 Merck & Co., Inc., the New Jersey-based pharmaceutical company, announced Tuesday May 26 they had agreed to purchase Themis Bioscience. The deal, executed for an โฆSee details»
Home - The Metabolomics Innovation Centre
The Metabolomics Innovation Centre (TMIC) is a nationally-funded core facility supported by the Canada Foundation for Innovation (CFI) Major Science Initiatives (MSI) program, Genome โฆSee details»
Themis: Two Renowned Vaccine Experts Joining Themis Bioscience โฆ
Jan 19, 2016 Themis Bioscience GmbH, a leading company developing prophylactic vaccines against emerging tropical infectious diseases, today announced the appointment of two new โฆSee details»
The exosome: a review of current therapeutic roles and capabilities โฆ
Exosomes are nano-vesicles (30โ150 nm) which may be useful as therapeutic delivery vehicles and as diagnostic biomarkers. Exosomes are produced naturally within the human body and โฆSee details»
OBIO - LinkedIn
OBIO | 12,177 followers on LinkedIn. Addressing the needs of the next generation of companies developing innovative human health products. | Founded in 2009, OBIO® is a not-for-profit, โฆSee details»
About - Telesis Bio
About Telesis Bio Telesis Bio Inc. is building biology. Creators of the BioXp ® system, the worldโs only fully automated gene synthesis platform, and the industry-standard Gibson Assembly ® โฆSee details»
My Account
Access and manage your Microsoft account and organizations.See details»
Leadership - Telesis Bio
About Telesis Bio Telesis Bio Inc. is building biology. Creators of the BioXp ® system, the worldโs only fully automated gene synthesis platform, and the industry-standard Gibson Assembly ® โฆSee details»